Sale of Lab To Unilever Endorsed

CAMBRIDGE, U.K.—The former director of the Plant Breeding Institute here has endorsed the government’s selection of Unilever as the new owner of the facility. The sale of the PBI and the National Seed Development Organization is part of Prime Minister Thatcher’s strategy to privatize many government-owned companies and institutions. The PBI is the country’s major institute for research on plant breeding, and the NSDO earned nearly $7 million last year by marketing se

Written byAlison Stewart
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

CAMBRIDGE, U.K.—The former director of the Plant Breeding Institute here has endorsed the government’s selection of Unilever as the new owner of the facility.

The sale of the PBI and the National Seed Development Organization is part of Prime Minister Thatcher’s strategy to privatize many government-owned companies and institutions. The PBI is the country’s major institute for research on plant breeding, and the NSDO earned nearly $7 million last year by marketing seeds from varieties bred at the PBI.

Unilever last month announced that it would buy the facilities for roughly $100 million, as of September 30. Its proposal topped bids from Imperial Chemical Industries (ICI) and the food group Booker.

A number of senior staff have left PBI since the government decided in May to sell the facilities. They feared that the sale would choke off a tradition of basic research and replace it with projects aimed at short-term ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies